Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Malignant neoplasm of breast
|
3417 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.040 | 0.750 | 4 | 2007 | 2014 | ||||||
Breast Carcinoma
|
2793 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.040 | 0.750 | 4 | 2007 | 2014 | ||||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Colorectal Carcinoma
|
1962 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2013 | 2013 | ||||||
Malignant Neoplasms
|
1641 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.030 | 1.000 | 3 | 2011 | 2013 | ||||||
Coronary Artery Disease
|
1577 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
Primary malignant neoplasm
|
1374 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2011 | 2013 | ||||||
Carcinoma of lung
|
1204 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||
Prostate carcinoma
|
1168 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 0.500 | 2 | 2008 | 2011 | ||||||
Crohn Disease
|
1147 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Malignant neoplasm of lung
|
1142 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||
Malignant neoplasm of prostate
|
1082 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 0.500 | 2 | 2008 | 2011 | ||||||
Primary malignant neoplasm of lung
|
981 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.020 | 1.000 | 2 | 2012 | 2018 | ||||||
Liver carcinoma
|
942 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.030 | 0.667 | 3 | 2011 | 2018 | ||||||
Ulcerative Colitis
|
827 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Diabetes Mellitus
|
824 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Non-Small Cell Lung Carcinoma
|
712 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Diabetes
|
710 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Ischemic stroke
|
704 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Stomach Carcinoma
|
652 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Malignant neoplasm of stomach
|
615 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Cerebrovascular accident
|
591 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Glioma
|
353 | 0.583 | 0.560 | 1 | 186673926 | 3 prime UTR variant | A/G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 |